Prostate biopsy in New York: the highest-volume physicians
242 physicians in New York billed Medicare for 7,908 prostate biopsy procedures in 2024. The top 25, with the year before beside it.
Top 25
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Tso-Jen Hsiao, MDUrology · Plainview | 411 | 359 | +14% |
| 2 | Theodore P. Felderman, MDUrology · Plainview | 239 | 206 | +16% |
| 3 | Samir Taneja, MDUrology · New York | 199 | 180 | +11% |
| 4 | Ashutosh Tewari, MDUrology · New York | 187 | 189 | −1% |
| 5 | Jonathan S. Fainberg, MD, MPHUrology · Fresh Meadows | 177 | 125 | +42% |
| 6 | Arnold P. Teo, MDUrology · Liverpool | 166 | 208 | −20% |
| 7 | James S. Wysock, MDUrology · Flushing | 148 | 107 | +38% |
| 8 | Massimiliano Spaliviero, MD, FACSUrology · Uniondale | 131 | 96 | +36% |
| 9 | Timothy D. Mcclure, MDUrology · New York | 122 | 113 | +8% |
| 10 | Ahmed E. Ghazi, MDUrology · Rochester | 114 | 48 | +138% |
| 11 | Gary D. Goldberg, MDUrology · Manhasset | 109 | 65 | +68% |
| 12 | Jim C. Hu, MD MPHUrology · New York | 102 | 78 | +31% |
| 13 | Behfar Ehdaie, MDUrology · New York | 96 | 87 | +10% |
| 14 | Timothy K. Byler, MDUrology · Syracuse | 87 | 60 | +45% |
| 15 | Anthony T. Corcoran, MDUrology · Garden City | 83 | 99 | −16% |
| 16 | Reza Ghavamian, MDUrology · Bronx | 82 | 83 | −1% |
| 17 | Alfred D. Kohan, MDUrology · Plainview | 79 | 76 | +4% |
| 18 | Michael J. Schwartz, MDUrology · New Hyde Park | 78 | 69 | +13% |
| 19 | Nedim Ruhotina, MDUrology · Liverpool | 70 | 39 | +79% |
| 20 | Rajiv Saini, MDUrology · Brooklyn | 67 | 39 | +72% |
| 21 | Wei Phin Tan, MDUrology · New York | 66 | 55 | +20% |
| 22 | Badar M. Mian, MDUrology · Albany | 65 | 69 | −6% |
| 23 | Brandon J. OttoUrology · Saratoga Springs | 60 | 55 | +9% |
| 23 | Thomas Rechtschaffen, MDUrology · Yonkers | 60 | 107 | −44% |
| 25 | Michael A. GorinUrology · Greenlawn | 58 | 53 | +9% |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.